キナーゼ生物学サービス市場- 世界の産業規模、シェア、動向、機会、予測、種類別、用途別、地域別、競争別、2020-2030F

キナーゼ生物学サービスの世界市場規模は2024年に10億8,000万米ドルとなり、2030年までのCAGRは10.02%で、堅調な成長が予測されています。

キナーゼ生物学サービスの世界市場は、広範なライフサイエンスおよび製薬産業の中で、重要かつダイナミックなセクターとして浮上しています。様々な細胞プロセスを制御する酵素の一種であるキナーゼは、創薬や薬剤開発において絶大な重要性を獲得しており、キナーゼは細胞の成長、増殖、分化、アポトーシスを含む多様な生物学的プロセスの制御に関与しています。キナーゼの調節異常は、しばしばがん、炎症性疾患、神経変性疾患などの疾患と関連しています。

その結果、キナーゼの研究は、疾病メカニズムの解明や潜在的な治療標的の同定に中心的な役割を果たすようになっています。世界の調査市場には、キナーゼ関連の研究をサポートするために調整された幅広いサービスと製品が含まれています。これらのサービスには、キナーゼアッセイ開発、ハイスループットスクリーニング、キナーゼプロファイリング、キナーゼ阻害剤スクリーニングなどが含まれます。これらのサービスにより、製薬会社やバイオテクノロジー企業、学術機関、研究機関は、潜在的な医薬品候補として使用できるキナーゼ阻害剤の同定と特性解析を行い、創薬を加速することができます。

市場促進要因

がんと慢性疾患の有病率の上昇

主な市場課題

キナーゼ生物学サービスの高コスト

主要市場動向

標的治療と個別化医療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のキナーゼ生物学サービス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（ELISAベースのテスト、酵素テスト、比色アッセイベースのテスト、その他）
  • 用途別（診断用、調査用）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のキナーゼ生物学サービス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のキナーゼ生物学サービス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のキナーゼ生物学サービス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のキナーゼ生物学サービス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのキナーゼ生物学サービス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Jena Bioscience GmbH
• Qiagen N.V.
• Merck & Co., Inc
• Promega Corporation
• Takara Bio Inc.
• Reaction Biology Corporation（RBC）
• Nanosyn

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Kinase Biology Services Market was valued at USD 1.08 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.02% through 2030. The Global Kinase Biology Services Market has emerged as a critical and dynamic sector within the broader life sciences and pharmaceutical industries. Kinases, a class of enzymes that regulate various cellular processes, have gained immense importance in drug discovery and development, making kin Kinases are involved in the regulation of diverse biological processes, including cell growth, proliferation, differentiation, and apoptosis. Dysregulation of kinases is often associated with diseases such as cancer, inflammatory disorders, and neurodegenerative conditions.

Consequently, the study of kinases has become central to understanding disease mechanisms and identifying potential therapeutic targets. The Global Kinase Biology Services Market encompasses a wide range of services and products tailored to support kinase-related research. These services include kinase assay development, high-throughput screening, kinase profiling, and kinase inhibitor screening, among others. They enable pharmaceutical and biotechnology companies, academic institutions, and research organizations to accelerate drug discovery by identifying and characterizing kinase inhibitors, which can be used as potential drug candidates.

Key Market Drivers

Rising Prevalence of Cancer and Chronic Diseases

Kinases are enzymes that regulate a wide range of cellular processes, including cell growth, division, and survival. In cancer and several chronic diseases, dysregulation of kinase activity is a common molecular hallmark. This makes kinases high-value therapeutic targets, especially in the development of targeted therapies and precision medicines. In 2022, global cancer incidence reached an estimated 20 million new cases, resulting in 9.7 million deaths. Additionally, approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting the increasing burden on healthcare systems and long-term care infrastructure. As the global burden of diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases continues to rise, there is a corresponding increase in demand for effective and targeted treatments. This creates a strong commercial incentive for pharmaceutical and biotechnology companies to focus their R&D efforts on kinase-related pathways, which in turn boosts demand for specialized kinase biology services.

Key Market Challenges

High Cost of Kinase Biology Services

The Global Kinase Biology Services Market has emerged as a critical player in the realm of drug discovery and disease understanding. Kinases, enzymes that regulate various cellular processes, hold immense potential in the development of targeted therapies. One primary reason for the elevated costs in kinase biology services is the complexity of the field itself. Kinase signaling pathways are intricate and multifaceted, requiring specialized knowledge, expertise, and cutting-edge technologies for their study. This complexity necessitates the involvement of skilled researchers and technicians who are well-versed in kinase biology, adding to the overall expenses. Another cost-driving factor is the need for sophisticated equipment and resources. Kinase assays, high-throughput screening, kinase profiling, and other related services rely heavily on state-of-the-art laboratory instrumentation. Maintaining and operating these tools, along with the cost of consumables and reagents, contribute significantly to the overall service fees. The high cost of kinase biology services can result in limited accessibility, particularly for smaller biotechnology companies, academic institutions, and emerging startups with constrained budgets. This accessibility gap can stifle innovation and prevent potentially groundbreaking research from reaching its full potential. It may also deter smaller entities from pursuing kinase-related projects, which could otherwise contribute significantly to the market's growth.

Key Market Trends

Targeted Therapies and Personalized Medicine

In the era of targeted therapies, the emphasis is on identifying and inhibiting specific molecular targets responsible for disease initiation and progression. Kinases frequently feature as these targets due to their central role in many diseases, making them attractive candidates for drug discovery efforts. The Global Kinase Biology Services Market is witnessing a surge in demand as pharmaceutical companies, research institutions, and biotechnology firms seek specialized services to identify and validate kinase inhibitors tailored to individual patients' genetic profiles. Personalized medicine hinges on the notion that every patient is unique, and treatments should reflect this individuality. As a result, kinase biology services have gained prominence in analyzing patients' genetic makeup to pinpoint the specific mutations or alterations in kinase activity driving their diseases. By tailoring therapies based on these genetic insights, clinicians can optimize treatment strategies, increasing efficacy and minimizing side effects. The application of personalized medicine extends beyond cancer, encompassing various chronic and rare diseases where kinase biology plays a pivotal role. This broadens the scope of the Kinase Biology Services Market, as researchers and pharmaceutical companies delve into the development of targeted therapies for conditions such as neurodegenerative disorders, autoimmune diseases, and cardiovascular ailments.

Key Market Players

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Jena Bioscience GmbH
• Qiagen N.V.
• Merck & Co., Inc
• Promega Corporation
• Takara Bio Inc.
• Reaction Biology Corporation (RBC)
• Nanosyn

Report Scope:

In this report, the Global Kinase Biology Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Biology Services Market, By Type:

• ELISA Based Tests
• Enzymatic Tests
• Colorimetric Assay Based Tests
• Others

Kinase Biology Services Market, By Application:

• Diagnosis Use
• Research Use

Kinase Biology Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kinase Biology Services Market.

Available Customizations:

Global Kinase Biology Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Biology Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (ELISA Based Tests, Enzymatic Tests, Colorimetric Assay Based Tests, Others)
  • 5.2.2. By Application (Diagnosis Use, Research Use)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Kinase Biology Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Kinase Biology Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Kinase Biology Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Kinase Biology Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Kinase Biology Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Kinase Biology Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Kinase Biology Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Kinase Biology Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Kinase Biology Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Kinase Biology Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Kinase Biology Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Kinase Biology Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Kinase Biology Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Kinase Biology Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Kinase Biology Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Kinase Biology Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Kinase Biology Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Kinase Biology Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Kinase Biology Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Kinase Biology Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Kinase Biology Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Kinase Biology Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Kinase Biology Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Kinase Biology Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd
• 15.3. Jena Bioscience GmbH
• 15.4. Qiagen N.V.
• 15.5. Merck & Co., Inc
• 15.6. Promega Corporation
• 15.7. Takara Bio Inc.
• 15.8. Reaction Biology Corporation (RBC)
• 15.9.Nanosyn

16. Strategic Recommendations

17. About Us & Disclaimer